1932

Abstract

The inhibition of thrombin is the key to the prevention and treatment of thrombotic disorders. Although heparin is an extremely effective anticoagulant, it has certain limitations that are not shared by newer thrombin inhibitors. As a result, these novel inhibitors may have advantages over heparin in certain clinical settings.

Loading

Article metrics loading...

/content/journals/10.1146/annurev.me.43.020192.000301
1992-02-01
2024-06-14
Loading full text...

Full text loading...

/content/journals/10.1146/annurev.me.43.020192.000301
Loading
  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error